- Case report
- Open Access
Identification of a novel TP63 mutation causing nonsyndromic cleft lip with or without cleft palate
BMC Medical Genomics volume 14, Article number: 53 (2021)
Cleft lip with or without cleft palate (CL/P) is the most common craniofacial anomaly with a high incidence of live births. The specific pathogenesis of CL/P is still unclear, although plenty of studies have been conducted. Variations of tumor protein 63 (TP63) was reported to be related to the phenotype of CL/P. The case discussed in this report involves a pedigree with mutation at TP63 gene, and the variation was not reported before.
A Chinese pedigree with CL/P was collected in this study. The proband is a 3-year-old boy with the phenotype of CL/P, while his global development and intelligence are normal. After two CL/P repair operations, he looks almost normal. The proband's uncle and grandmother both have the phenotype of CL/P. Cytogenetic analysis and chromosomal microarray analysis (CMA) were performed, followed by whole exome sequencing (WES) and sanger validation. Analysis of WES revealed a variant of C>T at nucleotide position 1324 (1324C>T) of TP63 gene, possibly producing a truncated protein with a premature stop codon at amino acid position 442 (p.Q442*). This mutation was localized at the oligomerization domain (OD) of TP63 and might impair the capacity of p63 oligomerization.
The mutation in TP63 was recognized to be the possible cause of the phenotype of CL/P in this pedigree. This report provides some evidence for the clinical diagnosis of CL/P. And our study also provides clinical evidence for the molecular mechanism of TP63 gene causing nonsyndromic cleft lip with or without cleft palate (NSCL/P).
CL/P is a serious congenital birth defect happened in about 1.7 per 1000 liveborn babies . It has become one of the most common developmental malformations in the world. In addition to facial deformities, functions including mastication, swallowing, pronunciation and respiration of patients would be affected to varying degrees, and even psychological development could be abnormal. Approximately 70% of CL/P occur as an isolated abnormality which was called NSCL/P .
CL/P is a disorder caused by the combination of genes and environmental interactions. At present, a variety of genetic pathogenic factors of CL/P are identified, including chromosome 8q24.21, 17q22 and 10q25.3, TGFα, TP63, IRF6, Runx2, etc. through different methods such as CMA, WES and so on [3,4,5,6,7,8]. However, the specific pathogenesis of NSCL/P is still unclear. Among these reported genes, TP63 is a key factor in the regulation of epithelial cell development, encoding a large number of p63 subtypes. It has been reported that the variation of TP63 could affect the binding ability of protein to DNA. Thomason et al. showed that the loss of TP63 function led to the phenotype of CL/P in mice .
In this study, we report the clinical findings detected in a Chinese pedigree (Fig. 1). Cytogenetic analysis and CMA of the pedigree members were normal. The proband was diagnosed by WES to be heterozygous for a C>T point mutation at nucleotide position 1324 (1324C>T) of TP63. The mutation was confirmed by sanger sequencing and it was not reported before.
The proband is a 3-year-old boy with healthy parents. He was full-term vaginally delivered with a birth weight of 3450 g and a length of 50 cm. Ultrasound examination revealed the signs of cleft lip and cleft palate during pregnancy of the proband's mother. Repair of cleft lip was performed 4 months after birth and palatoplasty was performed at 18 months old. At present, the proband's development and intelligence are normal without other deformities. The mother of the proband had a history of two terminations of pregnancy because of cleft lip and cleft palate of the fetus. The proband's uncle and grandmother both have the phenotype of cleft lip and cleft palate.
Cytogenetic analysis and CMA of the proband (Fig. 2) and other family members of the pedigree (data not shown) were normal. Results of WES analysis showed that the proband, the proband’s mother, uncle and grandmother carried the same c.1324C>T (p.Q442*) mutation in TP63 gene, possibly producing a truncated protein (Table 1). However, this mutation was absent in other family members as shown in the pedigree (Fig. 1) as well as healthy population controls. This c.1324C>T (p.Q442*) mutation of TP63 was not reported in literature before and also not found in NCBI dbSNP, genome AD, ExAC, and 1000 human genome dataset. Confirmation of Sanger sequencing was consistent with that of the WES (Fig. 3). In summary, this mutation can be interpreted as Likely Pathogenic according to ACMG guidelines .
Discussion and conclusion
All patients with the phenotype of CL/P had the same mutation site of TP63 in this pedigree. It has been reported that mutations in TP63 underlie several monogenic malformation syndromes manifesting CL/P including Rapp-Hodgkin syndrome, ankyloblepharon-ectodermal dysplasia-cleft lip/palate syndrome, ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome, limb-mammary syndrome, and acro-dermato-ungual-lacrimal-tooth syndrome . Leoyklang et al. investigated the possibility of TP63 mutation causing NSCL/P . Variation of TP63 was revealed to affect the binding ability of protein to DNA. Animal experiments in mice have found that loss of TP63 function led to the phenotype of CL/P . Study of Khandelwal et al. revealed that 6 of TP63 heterozygous variants detected in CL/P patients were inherited from an unaffected parent, suggesting reduced penetrance of such loss-of-function alleles. Incomplete penetrance has also been observed for other TP63 variants, including common variants such as those affecting arginine 319 (280accordingtoformernomenclature) . Therefore, it explained why the mother of the proband did not show the phenotype of CL/P, although she carried the same mutation in TP63. Clinical variability and reduced penetrance are typical for TP63 variants.
TP63 plays an important role in the regulation of limb, epithelial, and craniofacial development . This gene has at least six different isoforms, three of which containing the transactivating (TA) domain (TA isotypes) and the other three, none (△N isotypes). Alternative splicing at the 3′ end of the gene results in mainly three different C-terminal ends (α, β and γ). All isoforms contain a DNA-binding domain (DBD) and an OD, differing in the TA domain, sterilealpha-motif domain (SAM), auto-regulatory TA inhibiting domain (TI domain), and a second TA domain (TA2 domain) . Kantaputra et al. implied that mutation in SAM domain of TP63 is associated with NSCL/P . Khandelwal’s study indicated that missense variants affecting the OD might impair the capacity of p63 oligomerization . The 1324C>T mutation of TP63 in the pedigree is a nonsense mutation. The amino acid at 442 of TP63 was changed from glutamine to a termination codon (p.Q442 *), leading to the premature termination of peptide chain synthesis. TP63 mutation discussed in this report was localized in the OD (Fig. 4). This variant may abrogate the oligomerization of mutant p63 protein into oligomeric complexes, resulting in the phenotype of CL/P. Therefore, c.1324C>T variant of TP63 likely represents a loss-of-function allele rather than a dominant-negative pattern . The frequency of the mutation was not included in the NCBI dbSNP, genome AD, ExAC and 1000 Genomes databases. We speculate that the mutations of the TP63 gene (c.1324C>T) found in the Chinese family may be responsible for the phenotype of NSCL/P.
Although a variety of mutations in TP63 have been reported in patients with SCL/P or NSCL/P, in-depth studies are needed to explore the specific pathogenesis. Leoyklang et al. recognized that a mutation in TP63 causing NSCL/P may occur at a site different from those underlying mendelian malformation syndromes. The phenotypic differences depend on variability of TP63 expression (2). This report demonstrates that this novel 1324C>T mutation is associated with NSCL/P, which highlights the wide phenotypic spectrum of TP63 mutations.
Our study not only helps to reveal the pathogenic gene of the pedigree but also provides the research basis for the molecular mechanism of TP63 gene causing the phenotype of NSCL/P.
Availability of data and materials
The datasets generated during the current study are available in the NCBI Sequence Read Archive (SRA) database (accession number: PRJNA701188), direct link: https://www.ncbi.nlm.nih.gov/sra/PRJNA701188.
Cleft lip with or without cleft palate
Chromosomal microarray analysis
Whole exome sequencing
Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC. Cleft lip and palate. Lancet (London, England). 2009;374(9703):1773–85.
Leoyklang P, Siriwan P, Shotelersuk V. A mutation of the p63 gene in non-syndromic cleft lip. J Med Genet. 2006;43(6):e28.
Blanton SH, Burt A, Stal S, Mulliken JB, Garcia E, Hecht JT. Family-based study shows heterogeneity of a susceptibility locus on chromosome 8q24 for nonsyndromic cleft lip and palate. Birth Defects Res A. 2010;88(4):256–9.
Beaty TH, Murray JC, Marazita ML, Munger RG, Ruczinski I, Hetmanski JB, et al. A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat Genet. 2010;42(6):525–9.
Mangold E, Ludwig KU, Birnbaum S, Baluardo C, Ferrian M, Herms S, et al. Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat Genet. 2010;42(1):24–6.
Aberg T, Cavender A, Gaikwad JS, Bronckers AL, Wang X, Waltimo-Sirén J, et al. Phenotypic changes in dentition of Runx2 homozygote-null mutant mice. J Histochem Cytochem. 2004;52(1):131–9.
Ardinger HH, Buetow KH, Bell GI, Bardach J, VanDemark DR, Murray JC. Association of genetic variation of the transforming growth factor-alpha gene with cleft lip and palate. Am J Hum Genet. 1989;45(3):348–53.
Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell. 1999;99(2):143–53.
Thomason HA, Dixon MJ, Dixon J. Facial clefting in Tp63 deficient mice results from altered Bmp4, Fgf8 and Shh signaling. Develop Biol. 2008;321(1):273–82.
Kim BY, Park MH, Woo HM, Jo HY, Kim JH, Choi HJ, et al. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing. BMC Med Genet. 2017;18(1):106.
Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017;19(1):4–23.
van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, et al. p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet. 2001;69(3):481–92.
Khandelwal KD, van den Boogaard MH, Mehrem SL, Gebel J, Fagerberg C, van Beusekom E, et al. Deletions and loss-of-function variants in TP63 associated with orofacial clefting. Eur J Human Genet. 2019;27(7):1101–12.
Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398(6729):714–8.
Alves LU, Pardono E, Otto PA, Mingroni Netto RC. A novel c.1037C>G (p.Ala346Gly) mutation in TP63 as cause of the ectrodactyly-ectodermal dysplasia and cleft lip/palate (EEC) syndrome. Genet Mol Biol. 2015;38(1):37–41.
Kantaputra PN, Malaivijitnond S, Vieira AR, Heering J, Dötsch V, Khankasikum T, et al. Mutation in SAM domain of TP63 is associated with nonsyndromic cleft lip and palate and cleft palate. Am J Med Genet A. 2011;155a(6):1432–6.
We thank the patient and his family for taking part in this research.
Ethics approval and consent to participate
This study was approved by the Medical Ethics Committee of Hospital Affiliated 5 to Nantong University (Taizhou People’s Hospital). Written informed consent to participate was obtained from all the participants. The proband in this study is under the age of 16, and a written informed consent to participate was obtained from his legal guardians.
Consent for publication
Written informed consent for publication of identifying images or other personal or clinical details was obtained from all the participants or legal guardians of the proband who is under the age of 18.
The authors declare that there are no competing interests regarding the manuscript.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Xu, T., Du, M., Bu, X. et al. Identification of a novel TP63 mutation causing nonsyndromic cleft lip with or without cleft palate. BMC Med Genomics 14, 53 (2021). https://doi.org/10.1186/s12920-021-00903-4
- Cleft lip with or without cleft palate
- Nonsyndromic cleft lip with or without cleft palate
- Whole exome sequencing